Foundation Fighting Blindness logo

Foundation Fighting Blindness

North America, Maryland, United States, Columbia

Description

The Foundation intends to provide preventions, treatments & cures for people affected by entire spectrum of retinal degenerative diseases.

Investor Profile

Foundation Fighting Blindness has made 7 investments, with 2 in the past 12 months and 71% as lead.

Stage Focus

  • Series A (43%)
  • Grant (29%)
  • Seed (14%)
  • Series B (14%)

Country Focus

  • United States (86%)
  • France (14%)

Industry Focus

  • Health Care
  • Biotechnology
  • Therapeutics
  • Life Science
  • Pharmaceutical
  • Education
  • Universities
  • Health Diagnostics
  • Wellness
  • Neuroscience
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Foundation Fighting Blindness frequently co-invest with?

Hatteras Venture Partners
North America, North Carolina, United States, Durham
Co-Investments: 1
PBM Capital Group
North America, Virginia, United States, Charlottesville
Co-Investments: 1
4BIO Capital
Europe, England, United Kingdom, London
Co-Investments: 1
Retinal Degeneration Fund
North America, North Carolina, United States, Raleigh
Co-Investments: 1
Atlas Venture
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
University of Florida
North America, Florida, United States, Gainesville
Co-Investments: 1
OUP (Osage University Partners)
North America, Pennsylvania, United States, Bala Cynwyd
Co-Investments: 1
Mission BioCapital
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Bpifrance
Europe, Ile-de-France, France, Maisons-alfort
Co-Investments: 1
Maxim Group
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by Foundation Fighting Blindness?

Case Western Reserve University

Cleveland, Ohio, United States

Case Western Reserve University is a research-oriented university.

EducationUniversities
GrantJul 7, 2024
Amount Raised: $1,500,000
Opus Genetics

Raleigh, North Carolina, United States

Opus Genetics is a gene therapy company for ultra-rare blinding conditions.

Health CareHealth DiagnosticsWellness
GrantJun 13, 2024
Amount Raised: $1,700,000
Nacuity Pharmaceuticals

Fort Worth, Texas, United States

Nacuity Pharmaceuticals is a pharmaceutical company that aims to develop a breakthrough treatment for retinitis pigmentosa.

Health CarePharmaceutical
Series BJun 15, 2022
Amount Raised: $16,500,000
SparingVision

Paris, Ile-de-France, France

SparingVision is a biotechnology company developing genomic medicines for the treatment of blinding inherited retinal diseases.

BiotechnologyHealth CareLife Science
Series AOct 21, 2020
Amount Raised: $52,739,178
Atsena Therapeutics

Durham, North Carolina, United States

Atsena Therapeutics is a clinical-stage gene therapy company that develops novel treatments for inherited forms of blindness.

BiotechnologyHealth CareTherapeutics
Series AApr 1, 2020
Amount Raised: $8,150,000
Vedere Bio ll

Cambridge, Massachusetts, United States

Vedere Bio is developing gene therapy products to restore functional vision to patients who have suffered vision loss.

BiotechnologyHealth CareTherapeutics
Series AJun 1, 2019
Amount Raised: $21,000,000
MitoChem Therapeutics

Charleston, South Carolina, United States

MitoChem Therapeutics develops treatments to address the effects of mitochondrial dysfunction in neurodegenerative, aging, and disease.

BiotechnologyHealth CareLife ScienceNeurosciencePharmaceuticalTherapeutics
SeedApr 2, 2012
Amount Raised: $2,000,000